Urinary Bladder Neoplasms clinical trials

Explore recruiting urinary bladder neoplasms clinical trials.

Recruiting urinary bladder neoplasms studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Urinary Bladder Neoplasms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

J4G-MC-JZVD - FORAGER-2: A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Vepugratinib Combined with Enfortumab Vedotin and Pembrolizumab in Adults with Untreated Locally Advanced or Metastatic Urothelial Carcinoma with an FGFR3 Genetic Alteration.

Italy, Poland, Denmark, Czechia, France, Hungary +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Urinary Bladder Neoplasms trials by city

Urinary Bladder Neoplasms clinical trials

Recruiting urinary bladder neoplasms studies right now

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

A Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy

Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy in Patients Affected by Oligometastatic uRothelial carcinomA

A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer

Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial)

A Study of VET3-TGI in Patients With Solid Tumors

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery

Also recruiting in Europe

J4G-MC-JZVD - FORAGER-2: A Phase 3, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Vepugratinib Combined with Enfortumab Vedotin and Pembrolizumab in Adults with Untreated Locally Advanced or Metastatic Urothelial Carcinoma with an FGFR3 Genetic Alteration.

Urinary Bladder Neoplasms trials by city

Other conditions